The global objective of this study is to establish the safety and investigate the potential
treatment effect of an intravenous infusion of HB-adMSCs (Hope Biosciences adipose-derived
mesenchymal stem cells) on brain structure, neurocognitive/functional outcomes, and
neuroinflammation after traumatic brain injury and/or hypoxic-ischemic encephalopathy in
adults.
Phase:
Phase 2
Details
Lead Sponsor:
Hope Biosciences
Collaborator:
The University of Texas Health Science Center, Houston